MarketPulse
A

$ALPMY

2 articles found
1 positive
0 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Castration-Sensitive Prostate Cancer Market to Double to $11.75B by 2036

CSPC market projected to surge from $5.14B (2025) to $11.75B (2036), driven by aging populations, new drug approvals, and emerging therapies.
JNJMRKPFENVSAZN+2Xtandicastration-sensitive prostate cancer
The Motley FoolThe Motley Fool··Cory Renauer

Vir Biotech CEO Offloads $664K in Shares Amid Positive Clinical Pipeline

Vir Biotechnology CEO Marianne De Backer sold 72,559 shares worth $664,350, representing 6.76% of holdings. Sale aligns with historical patterns amid company's positive momentum.
VIRALPMYbiotechclinical trial results